Weiyue Lu - Search Results

Year	Number of Results
2003	2
2004	3
2005	6
2006	5
2007	5
2008	6
2009	9
2010	20
2011	14
2012	13
2013	11
2014	16
2015	23
2016	16
2017	29
2018	23
2019	13
2020	16
2021	12
2022	8
2023	10
2024	5

1

Drug Nanocrystals for Active Tumor-Targeted Drug Delivery.

Lu L, Xu Q, Wang J, Wu S, Luo Z, Lu W. Lu L, et al. Among authors: lu w. Pharmaceutics. 2022 Apr 6;14(4):797. doi: 10.3390/pharmaceutics14040797. Pharmaceutics. 2022. PMID: 35456631 Free PMC article. Review.

2

Brain tumor-targeted drug delivery strategies.

Wei X, Chen X, Ying M, Lu W. Wei X, et al. Among authors: lu w. Acta Pharm Sin B. 2014 Jun;4(3):193-201. doi: 10.1016/j.apsb.2014.03.001. Epub 2014 Apr 5. Acta Pharm Sin B. 2014. PMID: 26579383 Free PMC article. Review.

3

D-Peptides as Recognition Molecules and Therapeutic Agents.

Liu M, Li X, Xie Z, Xie C, Zhan C, Hu X, Shen Q, Wei X, Su B, Wang J, Lu W. Liu M, et al. Among authors: lu w. Chem Rec. 2016 Aug;16(4):1772-86. doi: 10.1002/tcr.201600005. Epub 2016 Jun 3. Chem Rec. 2016. PMID: 27255896 Review.

4

All-stage targeted therapy for the brain metastasis from triple-negative breast cancer.

Luo Z, Wu S, Zhou J, Xu W, Xu Q, Lu L, Xie C, Liu Y, Lu W. Luo Z, et al. Among authors: lu w. Acta Pharm Sin B. 2023 Jan;13(1):359-371. doi: 10.1016/j.apsb.2022.03.026. Epub 2022 Apr 6. Acta Pharm Sin B. 2023. PMID: 36815053 Free PMC article.

5

Pancreatic Cancer: Recent Progress of Drugs in Clinical Trials.

Zhang Z, Song J, Xie C, Pan J, Lu W, Liu M. Zhang Z, et al. Among authors: lu w. AAPS J. 2021 Feb 12;23(2):29. doi: 10.1208/s12248-021-00556-2. AAPS J. 2021. PMID: 33580411 Review.

6

Strategies of Combination Drug Delivery for Immune Checkpoint Blockades.

Ruan H, Bu L, Hu Q, Cheng H, Lu W, Gu Z. Ruan H, et al. Among authors: lu w. Adv Healthc Mater. 2019 Feb;8(4):e1801099. doi: 10.1002/adhm.201801099. Epub 2018 Dec 13. Adv Healthc Mater. 2019. PMID: 30548835 Review.

7

Ocular therapies with biomacromolecules: From local injection to eyedrop and emerging noninvasive delivery strategies.

Fan X, Jiang K, Geng F, Lu W, Wei G. Fan X, et al. Among authors: lu w. Adv Drug Deliv Rev. 2023 Jun;197:114864. doi: 10.1016/j.addr.2023.114864. Epub 2023 May 6. Adv Drug Deliv Rev. 2023. PMID: 37156266 Review.

8

Advance in Nanomedicine for Improving Mucosal Penetration and Effective Therapy of Cervical Cancer.

Liu Y, Yang Z, Feng L, Xia Y, Wei G, Lu W. Liu Y, et al. Among authors: lu w. Small. 2023 Jun 20:e2303772. doi: 10.1002/smll.202303772. Online ahead of print. Small. 2023. PMID: 37340569 Review.

9

Deciphering Protein Corona by scFv-Based Affinity Chromatography.

Chu Y, Tang W, Zhang Z, Li C, Qian J, Wei X, Ying T, Lu W, Zhan C. Chu Y, et al. Among authors: lu w. Nano Lett. 2021 Mar 10;21(5):2124-2131. doi: 10.1021/acs.nanolett.0c04806. Epub 2021 Feb 22. Nano Lett. 2021. PMID: 33617264

10

Recent advances in brain tumor-targeted nano-drug delivery systems.

Liu Y, Lu W. Liu Y, et al. Among authors: lu w. Expert Opin Drug Deliv. 2012 Jun;9(6):671-86. doi: 10.1517/17425247.2012.682726. Expert Opin Drug Deliv. 2012. PMID: 22607535 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

233 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Results by year